Your browser doesn't support javascript.
loading
Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions.
Schriek, Angela I; van Haaren, Marlies M; Poniman, Meliawati; Dekkers, Gillian; Bentlage, Arthur E H; Grobben, Marloes; Vidarsson, Gestur; Sanders, Rogier W; Verrips, Theo; Geijtenbeek, Teunis B H; Heukers, Raimond; Kootstra, Neeltje A; de Taeye, Steven W; van Gils, Marit J.
Afiliação
  • Schriek AI; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands.
  • van Haaren MM; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands.
  • Poniman M; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands.
  • Dekkers G; QVQ Holding BV, Utrecht, Netherlands.
  • Bentlage AEH; Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Grobben M; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands.
  • Vidarsson G; Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Sanders RW; Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands.
  • Verrips T; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, United States.
  • Geijtenbeek TBH; Department of Biology, Faculty of Sciences, Utrecht University, Utrecht, Netherlands.
  • Heukers R; VerLin BV, Utrecht, Netherlands.
  • Kootstra NA; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands.
  • de Taeye SW; QVQ Holding BV, Utrecht, Netherlands.
  • van Gils MJ; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands.
Front Immunol ; 13: 1091668, 2022.
Article em En | MEDLINE | ID: mdl-36483568
[This corrects the article DOI: 10.3389/fimmu.2022.893648.].
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda